Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]

Raffaella Calati; Concetta Crisafulli; Martina Balestri; Alessandro Serretti; Edoardo Spina; Marco Calabrò; Antonina Sidoti; Diego Albani; Isabelle Massat; Peter Höfer; Daniela Amital; Alzbeta Juven-Wetzler; Siegfried Kasper; Joseph Zohar; Daniel Souery; Stuart Montgomery; Julien Mendlewicz

doi:10.1016/j.pnpbp.2013.07.001

Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]

Raffaella Calati, Concetta Crisafulli, Martina Balestri, Alessandro Serretti, Edoardo Spina, Marco Calabrò, Antonina Sidoti, Diego Albani, Isabelle Massat, Peter Höfer, Daniela Amital, Alzbeta Juven-Wetzler, Siegfried Kasper, Joseph Zohar, Daniel Souery, Stuart Montgomery, Julien Mendlewicz

Istituto di Ricerche Farmacologiche "Mario Negri"

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	70
Number of pages	1
Journal	Progress in Neuro-Psychopharmacology and Biological Psychiatry
Volume	46
DOIs	https://doi.org/10.1016/j.pnpbp.2013.07.001
Publication status	Published - Oct 1 2013

ASJC Scopus subject areas

Biological Psychiatry
Pharmacology

Access to Document

10.1016/j.pnpbp.2013.07.001

Cite this

Calati, R., Crisafulli, C., Balestri, M., Serretti, A., Spina, E., Calabrò, M., Sidoti, A., Albani, D., Massat, I., Höfer, P., Amital, D., Juven-Wetzler, A., Kasper, S., Zohar, J., Souery, D., Montgomery, S., & Mendlewicz, J. (2013). Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 46, 70. https://doi.org/10.1016/j.pnpbp.2013.07.001

Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]. / Calati, Raffaella; Crisafulli, Concetta; Balestri, Martina et al.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 46, 01.10.2013, p. 70.

Research output: Contribution to journal › Article › peer-review

Calati, R, Crisafulli, C, Balestri, M, Serretti, A, Spina, E, Calabrò, M, Sidoti, A, Albani, D, Massat, I, Höfer, P, Amital, D, Juven-Wetzler, A, Kasper, S, Zohar, J, Souery, D, Montgomery, S & Mendlewicz, J 2013, 'Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]', Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 46, pp. 70. https://doi.org/10.1016/j.pnpbp.2013.07.001

Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M et al. Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 Oct 1;46:70. https://doi.org/10.1016/j.pnpbp.2013.07.001

Calati, Raffaella ; Crisafulli, Concetta ; Balestri, Martina et al. / Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; Vol. 46. pp. 70.

@article{a9f77fee3502414896c45eeb7d8916b4,

title = "Corrigendum to {"}Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.{"} [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]",

author = "Raffaella Calati and Concetta Crisafulli and Martina Balestri and Alessandro Serretti and Edoardo Spina and Marco Calabr{\`o} and Antonina Sidoti and Diego Albani and Isabelle Massat and Peter H{\"o}fer and Daniela Amital and Alzbeta Juven-Wetzler and Siegfried Kasper and Joseph Zohar and Daniel Souery and Stuart Montgomery and Julien Mendlewicz",

year = "2013",

month = oct,

day = "1",

doi = "10.1016/j.pnpbp.2013.07.001",

language = "English",

volume = "46",

pages = "70",

journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",

issn = "0278-5846",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]

AU - Calati, Raffaella

AU - Crisafulli, Concetta

AU - Balestri, Martina

AU - Serretti, Alessandro

AU - Spina, Edoardo

AU - Calabrò, Marco

AU - Sidoti, Antonina

AU - Albani, Diego

AU - Massat, Isabelle

AU - Höfer, Peter

AU - Amital, Daniela

AU - Juven-Wetzler, Alzbeta

AU - Kasper, Siegfried

AU - Zohar, Joseph

AU - Souery, Daniel

AU - Montgomery, Stuart

AU - Mendlewicz, Julien

PY - 2013/10/1

Y1 - 2013/10/1

UR - http://www.scopus.com/inward/record.url?scp=84880429143&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880429143&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2013.07.001

DO - 10.1016/j.pnpbp.2013.07.001

M3 - Article

AN - SCOPUS:84880429143

VL - 46

SP - 70

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -

Corrigendum to "Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients." [Progress in Neuro-Psychopharmacology & Biological Psychiatry 44 (2013) 271-278]

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this